메뉴 건너뛰기




Volumn 18, Issue 4, 2012, Pages 558-562

Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE; INSULIN LISPRO;

EID: 84864668198     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12042.OR     Document Type: Article
Times cited : (14)

References (19)
  • 1
    • 84861091595 scopus 로고    scopus 로고
    • How much do i give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus
    • King AB, Clark D, Wolfe GS. How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus. Endocr Pract. 2012;18:382-386.
    • (2012) Endocr Pract , vol.18 , pp. 382-386
    • King, A.B.1    Clark, D.2    Wolfe, G.S.3
  • 2
    • 77956622288 scopus 로고    scopus 로고
    • How much do i give? Reevaluation of insulin dosing estimation formulas using continuous glucose mon-itoring
    • King AB. How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose mon-itoring. Endocr Pract. 2010;16:428-432.
    • (2010) Endocr Pract , vol.16 , pp. 428-432
    • King, A.B.1
  • 3
    • 8144228075 scopus 로고    scopus 로고
    • Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with type 1 diabe-tes mellitus given meal-time lispro insulin
    • Porcellati F, Rossetti P, Pampanelli S, et al. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with type 1 diabe-tes mellitus given meal-time lispro insulin. Diabet Med. 2004;21:1213-1220.
    • (2004) Diabet Med , vol.21 , pp. 1213-1220
    • Porcellati, F.1    Rossetti, P.2    Pampanelli, S.3
  • 4
    • 67650090980 scopus 로고    scopus 로고
    • Comparison of A Multiple Daily Insulin Injection Regimen (basal Once-daily Glargine Plus Mealtime Lispro) and Continuous Subcutane-ous Insulin Infusion (lispro) in Type 1 Diabetes: A random-ized open parallel multicenter study published correction appears in Diabetes Care. 2009;32:1944
    • Bolli GB, Kerr D, Thomas R, et al. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutane-ous insulin infusion (lispro) in type 1 diabetes: a random-ized open parallel multicenter study published correction appears in Diabetes Care. 2009;32:1944. Diabetes Care. 2009;32:1170-1176.
    • (2009) Diabetes Care. , vol.32 , pp. 1170-1176
    • Bolli, G.B.1    Kerr, D.2    Thomas, R.3
  • 5
    • 0038587474 scopus 로고    scopus 로고
    • A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes
    • HOE9014007 Study Group
    • Hamann A, Matthaei S, Rosak C, Silvestre L (HOE901/4007 Study Group). A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care. 2003;26:1738-1744
    • (2003) Diabetes Care. , vol.26 , pp. 1738-1744
    • Hamann, A.1    Matthaei, S.2    Rosak, C.3    Silvestre, L.4
  • 6
    • 34247627840 scopus 로고    scopus 로고
    • Glargine versus NPH insu-lin: Effcacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes\the glargine and aspart study (GLASS); A randomised cross-over study
    • Chatterjee S, Jarvis-Kay J, Rengarajan T, Lawrence IG, McNally PG, Davies MJ. Glargine versus NPH insu-lin: effcacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes\the glargine and aspart study (GLASS); a randomised cross-over study. Diabetes Res Clin Pract. 2007;77:215-222.
    • (2007) Diabetes Res Clin Pract. , vol.77 , pp. 215-222
    • Chatterjee, S.1    Jarvis-Kay, J.2    Rengarajan, T.3    Lawrence, I.G.4    McNally, P.G.5    Davies, M.J.6
  • 7
    • 69349097283 scopus 로고    scopus 로고
    • Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with type 1 diabetes
    • Bolli GB, Songini M, Trovati M, et al. Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with type 1 diabetes. Nutr Metab Cardiovasc Dis. 2009;19:571-579.
    • (2009) Nutr Metab Cardiovasc Dis , vol.19 , pp. 571-579
    • Bolli, G.B.1    Songini, M.2    Trovati, M.3
  • 8
    • 0030880740 scopus 로고    scopus 로고
    • Roles of circa-dian rhythmicity and sleep in human glucose regulation
    • Van Cauter E, Polonsky KS, Scheen AJ. Roles of circa-dian rhythmicity and sleep in human glucose regulation. Endocr Rev. 1997;18:716-738.
    • (1997) Endocr Rev , vol.18 , pp. 716-738
    • Van Cauter, E.1    Polonsky, K.S.2    Scheen, A.J.3
  • 9
    • 17844384260 scopus 로고    scopus 로고
    • Optimal insulin pump dosing and post-prandial glycemia following a pizza meal using the con-tinuous glucose monitoring system
    • Jones SM, Quarry JL, Caldwell-McMillian M, Mauger DT, Gabbay RA. Optimal insulin pump dosing and post-prandial glycemia following a pizza meal using the con-tinuous glucose monitoring system. Diabetes Technol Ther. 2005;7:233-240.
    • (2005) Diabetes Technol Ther , vol.7 , pp. 233-240
    • Jones, S.M.1    Quarry, J.L.2    Caldwell-Mcmillian, M.3    Mauger, D.T.4    Gabbay, R.A.5
  • 10
    • 3442891969 scopus 로고    scopus 로고
    • The diabetic stomach: Management strat-egies for clinicians and patients
    • Bernstein G. The diabetic stomach: management strat-egies for clinicians and patients. Diabetes Spectrum. 2000;13:11-21.
    • (2000) Diabetes Spectrum , vol.13 , pp. 11-21
    • Bernstein, G.1
  • 11
    • 78651441889 scopus 로고    scopus 로고
    • Glycaemic rises after waking up in response to an alarm clock in type 1-diabetic patients ana-lysed with continuous glucose monitoring (GlucoDay® S)
    • Berndt-Zipfel C, Köthe L, Nawrodt B, Mraz B, Patzelt-Bath A, Nauck MA. Glycaemic rises after waking up in response to an alarm clock in type 1-diabetic patients ana-lysed with continuous glucose monitoring (GlucoDay® S). Exp Clin Endocrinol Diabetes. 2011;119:56-58.
    • (2011) Exp Clin Endocrinol Diabetes , vol.119 , pp. 56-58
    • Berndt-Zipfel, C.1    Köthe, L.2    Nawrodt, B.3    Mraz, B.4    Patzelt-Bath, A.5    Nauck, M.A.6
  • 12
    • 0033661254 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
    • Lepore M, Pampanelli S, Fanelli C. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and Ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes. 2000;49:2142-2148.
    • (2000) Diabetes. , vol.49 , pp. 2142-2148
    • Lepore, M.1    Pampanelli, S.2    Fanelli, C.3
  • 13
    • 84977684219 scopus 로고
    • The infuence of fasting on the blood sugar in diabetes
    • Hatlehol R. The infuence of fasting on the blood sugar in diabetes. Acta Med Scand. 1924;60(suppl 8):176-180.
    • (1924) Acta Med Scand. , vol.60 , Issue.SUPPL. 8 , pp. 176-180
    • Hatlehol, R.1
  • 14
    • 0021842667 scopus 로고
    • Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus: Accelerated glucose production and impaired glucose utilization due to noc-turnal surges in growth hormone secretion
    • Campbell PJ, Bolli GB, Cryer PE, Gerich JE. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus: accelerated glucose production and impaired glucose utilization due to noc-turnal surges in growth hormone secretion. N Engl J Med. 1985;312:1473-1479.
    • (1985) N Engl J Med , vol.312 , pp. 1473-1479
    • Campbell, P.J.1    Bolli, G.B.2    Cryer, P.E.3    Gerich, J.E.4
  • 15
    • 23644448095 scopus 로고    scopus 로고
    • The dawn phenomenon revis-ited: Implications for diabetes therapy
    • Carroll MF, Schade DS. The dawn phenomenon revis-ited: implications for diabetes therapy Endocr Pract. 2005; 11:55-64.
    • (2005) Endocr Pract , vol.11 , pp. 55-64
    • Carroll, M.F.1    Schade, D.S.2
  • 16
    • 0025958256 scopus 로고
    • The dawn phenom-enon in type 1 (insulin-dependent) diabetes mellitus: Mag-nitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity
    • Perriello G, De Feo P, Torlone E, et al. The dawn phenom-enon in type 1 (insulin-dependent) diabetes mellitus: mag-nitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity Diabetologia. 1991;34:21-28.
    • (1991) Diabetologia , vol.34 , pp. 21-28
    • Perriello, G.1    De Feo, P.2    Torlone, E.3
  • 17
    • 1542787613 scopus 로고    scopus 로고
    • Comparison of insulin aspart and lispro: Pharma-cokinetic and metabolic effects
    • Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G. Comparison of insulin aspart and lispro: pharma-cokinetic and metabolic effects. Diabetes Care. 2003;26: 2027-2031.
    • (2003) Diabetes Care , vol.26 , pp. 2027-2031
    • Homko, C.1    Deluzio, A.2    Jimenez, C.3    Kolaczynski, J.W.4    Boden, G.5
  • 18
    • 67649151481 scopus 로고    scopus 로고
    • A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Bolus dosing
    • King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing. J Diabetes Sci Technol. 2007;1:42-46.
    • (2007) J Diabetes Sci Technol. , vol.1 , pp. 42-46
    • King, A.B.1    Armstrong, D.U.2
  • 19
    • 84860577107 scopus 로고    scopus 로고
    • Development of optimal kids insulin dosing system formu-las for young children with type 1 diabetes mellitus
    • pub-lished online ahead of print January 12, 2012 PMID: 22239470
    • Alemzadeh R, Hoffmann RG, Dasgupta M, Parton E. Development of optimal kids insulin dosing system formu-las for young children with type 1 diabetes mellitus pub-lished online ahead of print January 12, 2012. Diabetes Technol Ther. PMID: 22239470.
    • Diabetes Technol Ther
    • Alemzadeh, R.1    Hoffmann, R.G.2    Dasgupta, M.3    Parton, E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.